C. Charpin et al., QUANTITATIVE IMMUNOCYTOCHEMICAL ASSAYS ON FROZEN-SECTIONS OF P53 - CORRELATION TO THE FOLLOW-UP OF PATIENTS WITH BREAST CARCINOMAS, American journal of clinical pathology, 106(5), 1996, pp. 640-646
A series of 222 turner samples stored at -80 degrees C in the authors'
tumor library were investigated with anti-p53 (PA 1801)and streptavid
in-biotin-peroxidase complex. The p53 immunoprecipitates were quantifi
ed by densitometry assessed by image analysis of digitized microscopic
images. Two parameters, percentage of positive surface and mean optic
al densities, were compared with the patient's outcome (follow-up = 96
.8 months) (life table method, Mantel Cos test, BMDP statistical softw
are). The p53 expression significantly correlated with a poor overall
survival (P = .0063), metastasis-free survival (P = .024), and recurre
nce-free survival (P = .022) at a 20% cutoff point of positive immunor
eactive tumor surface. A strong prognostic significance,vas observed i
n the node-positive subset of patients but not in the node-negative su
bset, except for recurrence-free survival (P = .047). The results indi
cate the clinical relevance of p53 evaluated by quantitative immunocyt
ochemistry.